TerminatedPhase 2

Intravitreal Bevacizumab for Age-Related Macular Degeneration

Stopped: undefined

Mexico50 participantsStarted 2005-09

Plain-language summary

The purpose of this study is to determine whether intravitreal injection of bevacizumab is effective in the treatment of neovascular age related macular degeneration

Who can participate

Age range50 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age \>50 age related macular degeneration Exclusion Criteria: * moderate to severe cataract glaucoma intraocular surgery diabetes mellitus non controlled hypertension coronary artery disease

What they're measuring

Improvement of visual acuity at 6 months

Trial details

NCT IDNCT00347165

SponsorAsociación para Evitar la Ceguera en México

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2006-06

View on ClinicalTrials.gov More Age Related Macular Degeneration trials